Amgen is expanding in RI with a new $160-million next-gen biomanufacturing plant that will be the first of its kind in the U.S. The facility will be supported by incentives from RI’s innovative economic development programs. The new biomanufacturing plant will be built on Amgen’s current 75-acre campus in West Greenwich and is expected to create approximately 150 additional highly-skilled manufacturing positions. The new plant will employ Amgen’s next-gen biomanufacturing capabilities and wil...